top of page
IMPORTANT: PATIENT PORTAL CHANGE
NOTICE TO PATIENTS
On July 12, Dr. McCarthy emailed patients an invitation to activate their new SimplePractice portal (sent from "yourprovider@simplepractice.com"). Please call or email Dr. McCarthy (703-288-3535 / operations@catherinemccarthymd.com) with any questions.
Thank you for your patience!
NOTICE TO PATIENTS
Search


“This Is Going to Make Our Lives Even Harder:” CDC Warns of More Stimulant Disruptions
ADDitude readers react to news that the ADHD medication shortage may worsen, following the arrests of Done ADHD executives for alleged...


CDC Warns of Increased ADHD Drug Shortages, Untreated Symptoms
Written by Lisa O’Mary June 14, 2024 – The process of finding stimulant medications that treat conditions such as attention deficit...

Founder/CEO and Clinical President of Digital Health Company Arrested for $100M Adderall Distribution and Health Care Fraud Scheme
Thursday, June 13, 2024 Share For Immediate Release Office of Public Affairs Justice Department’s First Criminal Drug Distribution...


CDC warns access to ADHD meds may be disrupted after arrests of health-care startup executives
The new CDC advisory noted that there is an ongoing shortage in the United States involving several stimulant medications commonly...

Disrupted Access to Prescription Stimulant Medications Could Increase Risk of Injury and Overdose
Original Story Distributed via the CDC Health Alert NetworkJune 13, 2024, 1:00 PM ETCDCHAN-00510 SummaryThe Centers for Disease Control...


Untreated ADHD is A Public Health Issue
Catherine L. McCarthy, MD and Susan B. Trachman, MD Jun 10, 2024 Op-Med is a collection of original articles contributed by Doximity...


A Way You Can Address the Medication Shortage: Write a Letter
Sample Letter with links to find your representatives Original News Source We have heard the frustrations many members of the ADHD...
How a health-care cyberattack may affect your prescription drug access
March 5, 2024 The Washington Post 'The reason behind the chaos is a ransomware attack on a little-known company called Change Healthcare,...


How a health-care cyberattack may affect your prescription drug access
A cyberattack on a health-care company has created problems for many patients trying to fill drug prescriptions. For some consumers, the...


FTC, HHS Request Patient Information on Drug Shortages, Pharmaceutical Middlemen
As the ADHD medication shortage drags on, the Federal Trade Commission and U.S. Department of Health and Human Services seek public input...


The Empty Adderall Factory
A drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis — at a rate of 600 million missing doses a year. Intellegencer...


"A horrible, perfect storm": Frustrations rise as shortage of Adderall, other ADHD medication continues
All Jennifer Howell wanted was to find medication for her son. Instead, she was caught in a maze of desperate phone calls to pharmacies...


Why is there an ADHD medication shortage in 2024? What's making generics of Vyvanse, Adderall and more so scarce
Supply from drugmakers for the stimulant medications most commonly prescribed for ADHD are still falling short of demand, the Food and...


‘I’m fed up’: Frustrations grow as ADHD drug shortage continues
More than a year after the Food and Drug Administration announced a nationwide shortage of Adderall, doctors and patients say they are...


No end in sight for ADHD medication shortages
It has been over a year since the FDA reported the initial medication shortage, Adderall due to a manufacturer delay, and today multiple...


DEA, Drug Manufacturers Trade Blame for Generic Adderall, Vyvanse Shortages
As the generic Adderall shortage extends to Vyvanse and Ritalin, the DEA says it has taken steps to increase ADHD medication production...


House Democrats demand answers on year-long Adderall shortage
A group of House Democrats is calling on the Food and Drug Administration (FDA) to explain what the agency is doing to address the...


The A.D.H.D. Drug Shortage Is Causing Real Pain
Each manufacturer has a specific limit and the D.E.A. claims that some have extra doses that they could sell. Individual companies, in...


Joint letter to Americans by the heads of the FDA and DEA
Given the interest related to access to these medications, we want to provide an update on the ongoing actions being taken to resolve the...


Opioid Settlement Hinders Patients’ Access to a Wide Array of Drugs
Nearly a year after a sweeping opioid settlement imposed new requirements on the companies that provide medications to pharmacies,...
bottom of page